Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the dominant subtype of renal cancer. With currently available therapies, cure of advanced and metastatic ccRCC is achieved only in rare cases. Here, we developed a workflow integrating different -omics technologies to identify ccRCC-specific HL...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genome Med
Main Authors: Reustle, Anna, Di Marco, Moreno, Meyerhoff, Carolin, Nelde, Annika, Walz, Juliane S., Winter, Stefan, Kandabarau, Siahei, Büttner, Florian, Haag, Mathias, Backert, Linus, Kowalewski, Daniel J., Rausch, Steffen, Hennenlotter, Jörg, Stühler, Viktoria, Scharpf, Marcus, Fend, Falko, Stenzl, Arnulf, Rammensee, Hans-Georg, Bedke, Jens, Stevanović, Stefan, Schwab, Matthias, Schaeffeler, Elke
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7106651/
https://ncbi.nlm.nih.gov/pubmed/32228647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-020-00731-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados